Generated: May 29, 2017
|Title:||Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline|
|Abstract:||Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNF.alpha. in a mammal.|
|Inventor(s):||Muller; George W. (Bridgewater, NJ), Stirling; David I. (Branchburg, NJ), Chen; Roger Shen-Chu (Edison, NJ)|
|Assignee:||Celgene Corporation (Summit, NJ)|
1. An oral dosage form in the form of a capsule or a tablet comprising a therapeutically effective amount of compound of the formula: ##STR00007## or an acid addition
salt thereof, and a pharmaceutically acceptable excipient.
2. The oral dosage form of claim 1, wherein the compound is present at an amount of from 1 to 100 mg.